Ep 101: Innovations in Atopic Dermatitis Treatment - 2025 Annual SF Derm | The Future of Dermatology

Summary In this truncated replay from a session at the 2025 SF Derm Annual Conference, Dr. Lawrence Eichenfield discusses the latest advancements in the treatment of atopic dermatitis, focusing on new topical and systemic therapies, the role of corticosteroids, and the evolving perspectives on patient care. He highlights the importance of understanding both the benefits and concerns associated with various treatments, including the impact of media on patient perceptions. Takeaways We have new topical agents for atopic dermatitis. Topical corticosteroids are like hammers for eczema. Topical steroid addiction is a real concern. We have lots of options for atopic dermatitis. New non-steroidals are being approved for younger patients. Dupilomab shows promise in remission data. Topical care remains a cornerstone of treatment. We need to defend topical corticosteroids. Long-term safety data is crucial for new therapies. Patients often fear topical steroid withdrawal. Chapters 00:00 - Introduction to Atopic Dermatitis Innovations 02:46 - Emerging Therapies for Atopic Dermatitis 04:33 - Topical Corticosteroids: Benefits and Concerns 08:30 - Understanding Topical Steroid Withdrawal 08:46 - New Non-Steroidal Treatments for Atopic Dermatitis